Apexon signs AWS deal for agentic AI in healthcare

Key Takeaways

• Apexon partners with AWS to deliver Agentic AI solutions for healthcare and life sciences organizations
• The collaboration aims to accelerate AI deployment, cloud-native modernization, and full-stack digital engineering
• Expected benefits include 30-50% productivity improvements across regulated workflows
• Joint development of domain-specific agentic AI solutions will focus on six priority areas

Introduction to Apexon and AWS Partnership

Apexon, a leading digital solutions provider, has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS) to deliver Agentic AI deployment, cloud-native modernization, and full-stack digital engineering solutions for healthcare and life sciences organizations. This partnership builds on over 100 successful AWS engagements and combines Apexon's AgentRise Agentic AI platform with AWS's purpose-built healthcare and life sciences infrastructure.

Benefits of the Partnership

The collaboration will enable faster operationalization of production-grade AI agents across clinical, commercial, and operational functions. Additionally, it will accelerate the migration of legacy workloads onto a modern cloud foundation, with a delivery model where engineering, AI deployment, and infrastructure operations are owned by a single accountable team. Leading BioPharma organizations have validated that these capabilities can drive 30 to 50 percent productivity improvements across regulated workflows.

Comparison of Apexon and AWS Solutions

Priority Areas for Joint Development

Apexon and AWS will jointly develop and deploy domain-specific agentic AI solutions across six priority areas:

Research and Development

Accelerating drug discovery and compound analysis through AI-driven research workflows

Clinical Trials

Optimizing trial operations and reducing clinical document drafting time by up to 50 percent

Commercial and Medical Affairs

Empowering field teams with AI-driven intelligence

Bottom Line

The partnership between Apexon and AWS is expected to drive significant benefits for healthcare and life sciences organizations, including improved productivity, accelerated AI deployment, and enhanced patient outcomes. With a focus on six priority areas, this collaboration has the potential to transform the healthcare and life sciences industry through the power of Agentic AI and cloud-native modernization.